HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type 2 Cyclic Nucleotide Phosphodiesterases

A cyclic nucleotide phosphodiesterase subfamily that is activated by the binding of CYCLIC GMP to an allosteric domain found on the enzyme. Multiple enzyme variants of this subtype can be produced due to multiple alternative mRNA splicing. The subfamily is expressed in a broad variety of tissues and may play a role in mediating cross-talk between CYCLIC GMP and CYCLIC CMP pathways. Although the type 2 enzymes are classified as 3',5'-cyclic-AMP phosphodiesterases (EC 3.1.4.17), members of this class have additional specificity for CYCLIC GMP.
Also Known As:
Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic GMP-Stimulated Phosphodiesterase; Cyclic Nucleotide Phosphodiesterase PDE2 Family; Cyclic Nucleotide Phosphodiesterases, Type 2A; PDE2 Phosphodiesterase; PDE2 Phosphodiesterases; Phosphodiesterase 2A; cGMP-Dependent 3',5'-Cyclic Phosphodiesterase; 3',5'-Cyclic Phosphodiesterase, cGMP-Dependent; Cyclic GMP Stimulated Phosphodiesterase; Phosphodiesterase, Cyclic GMP-Stimulated; cGMP Dependent 3',5' Cyclic Phosphodiesterase
Networked: 20 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Iwashita, Hiroki: 5 articles (12/2019 - 01/2017)
2. Taniguchi, Takahiko: 4 articles (01/2018 - 01/2017)
3. Nakashima, Masato: 3 articles (12/2019 - 01/2017)
4. Suzuki, Noriko: 3 articles (12/2019 - 01/2017)
5. Imada, Haruka: 3 articles (01/2018 - 01/2017)
6. Mikami, Satoshi: 3 articles (01/2017 - 01/2017)
7. Oki, Hideyuki: 3 articles (01/2017 - 01/2017)
8. Bardoni, Barbara: 2 articles (01/2022 - 01/2019)
9. Jarjat, Marielle: 2 articles (01/2022 - 01/2019)
10. Melancia, Francesca: 2 articles (01/2022 - 01/2019)

Related Diseases

1. Cognitive Dysfunction
2. Schizophrenia (Dementia Praecox)
3. Ganglion Cysts (Ganglion)
4. Hypoxia (Hypoxemia)
5. Fragile X Syndrome (Martin Bell Syndrome)

Related Drugs and Biologics

1. TAK-915
2. N-Methyl-D-Aspartate Receptors (NMDA Receptors)
3. Cyclic Nucleotide-Gated Cation Channels
4. GTP-Binding Proteins (G-Protein)
5. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
6. Ion Channels (Ion Channel)
7. Pyrazines
8. Proteins (Proteins, Gene)
9. Phytochrome
10. Phosphoric Diester Hydrolases (Phosphodiesterases)

Related Therapies and Procedures

1. Therapeutics